Carol Monaghan
Main Page: Carol Monaghan (Scottish National Party - Glasgow North West)(9 years, 2 months ago)
Westminster HallWestminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.
Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
Indeed, this is a good investment, which is why the Government have been supporting our science base over time. We recognise the huge economic benefits that it brings to the country.
I was in the middle of describing the investments we are making in cardiovascular and other medical technologies research. We have supplemented the ongoing spending of the MRC and the NIHR by announcing a couple of new innovation institutions, which will be extremely helpful to the sector in developing new medical technologies. We have just announced a new medicines technologies catapult, which will be based at Alderley Park in Cheshire. We have also announced the headquarters of the new precision medicine catapult in Cambridge, which will have one of its five centres of excellence in the north of England. The hon. Member for Cambridge (Daniel Zeichner) focused on excellence in Cambridge. I am happy to tell him that I was in Cambridge last week and saw the laboratory of molecular biology. I was as impressed as his comments would have led me to expect—it is an extraordinary centre, and we have every intention of continuing to ensure that it remains one of the world’s leading research institutes.
The examples that Members have already cited, such as Cambridge and the scientific centres in the northern powerhouse, are good examples of why Britain is such a powerhouse in the world of science and why we want to ensure that we make Britain the best place in the world to do science. Our global scientific impact is completely out of proportion with both our population and the size of our research spend as a share of global research and development expenditure. The UK punches well above its weight.
Does the Minister agree that, although we are doing extremely well in science at the moment, there is concern in the scientific community that emerging markets in east Asia and India will overtake the UK’s scientific research if funding is not continued and increased?
We have discussed that question at great length in Select Committees and, of course, we understand that the impact of our science spend is a function both of the efficiency of our science base and of the inputs that go into it—the amount of money that we spend every year on science. The hon. Lady will recognise that we underscored our commitment to science in the last Parliament by ring-fencing expenditure at £4.6 billion at a time of discretionary savings across the rest of Government activity to the tune of £98 billion. Furthermore, she will know from our previous discussions and from Government documents that we have committed to a road map for capital expenditure all the way to 2021 to the tune of £1.1 billion per annum, which will give businesses, researchers and charities the certainty they need about the role that the Government intend to play in investing in our science base.